Ellipsis Health Announces Formation of New Advisory Board

News provided by

May 05, 2022, 09:00 ET

With deep expertise across all facets of healthcare, 20 industry leaders will provide strategic counsel and guidance to Ellipsis Health

SAN FRANCISCO, May 5, 2022 /PRNewswire/ -- In conjunction with Mental Health Awareness Month in May, Ellipsis Health today announced the creation of an Advisory Board composed of industry experts across the entire healthcare ecosystem. The Advisory Board will provide strategic advice and guidance to Ellipsis Health as the company brings to market its technology that identifies, measures, and monitors the severity of stress, anxiety, and depression at scale.

"Our new advisory board includes innovative leaders with diverse experience and knowledge across industries from healthcare to technology to business that will help guide Ellipsis Health as we continue to scale our business for the future," said Mainul Mondal, founder and CEO, Ellipsis Health. "I am looking forward to working with each distinguished Advisory Board member to harness the unique power of the human voice as a biomarker for mental health and improve clinical outcomes."

The Ellipsis Health Advisory Board includes the following distinguished leaders:

Rajesh Aggarwal, MD, PhD, Chief Growth and Strategy Officer, Panda Health
Sunil Bharitkar, Ph.D., Principal Scientist, AI Research, Samsung Research
Timothy L. Blevins, Former Senior Vice President, Optum
Joanne Bradford, Chief Growth Officer, MNTN
Ryan Brooks, Executive Vice President of Government Affairs, Outfront Media
Warren S. Browner, MD, MPH, CEO, California Pacific Medical Center and Area CEO, Sutter Health West Bay Hospitals
Victor G. Carrion, MD, the John A. Turner, M.D., Professor of Child and Adolescent Psychiatry at Stanford University School of Medicine and Vice-Chair of the Department of Psychiatry and Behavioral Sciences
Helmy Eltoukhy, Co-Founder, Co-Chief Executive Officer and Chairman of the Board of Directors, Guardant Health
Walter Greenleaf PhD, Neuroscientist, Virtual Reality, and Digital Health Expert at Stanford University Virtual Human Interaction Lab
Amyn Jan, Chief Strategist, US Federal Government
Gary Loveman, Co-Founder, Chairman and CEO of Well and Former Executive Vice President, Consumer Health Services, Aetna
Divesh Makan, Co-Founder and CEO of ICONIQ Capital, LLC.
Ricardo Villela Marino, Partner, Itaú Unibanco and Chairman of the bank's Latin America Strategic Council
Dr. Gregory Moore, Corporate Vice President, Microsoft Health & Life Sciences
Deanna M. Mulligan, Chief Executive Officer, Purposeful and Former, President and CEO, Guardian Life
Mike Nill, Former Chief Operating Officer and Chief Engineering Officer, Cerner Corporation
Jerry Perullo, Chief Information Security Officer, Intercontinental Exchange, Inc.
Rick Schlesinger, Former Senior Partner, McKinsey & Company
Andrew Thompson, Managing Director and Co-Founder, Spring Ridge Ventures
Richard Socher, Chief Executive Officer, you.com and Former Chief Scientist, Executive Vice President, Salesforce

"The advancement of innovative mental health technologies like Ellipsis Health is vital to closing care gaps and making quality mental health accessible for all," said Victor G. Carrion, MD, the John A. Turner, M.D., Professor of Child and Adolescent Psychiatry at Stanford University School of Medicine and Vice-Chair of the Department of Psychiatry and Behavioral Sciences. "I am pleased to lend my expertise and clinical perspective to help Ellipsis Health address these critical issues."

About Mental Health Awareness Month
Each year millions of Americans face the reality of living with a mental illness. During May, National Alliance on Mental Illness (NAMI) joins the national movement to raise awareness about mental health. Each year we fight stigma, provide support, educate the public and advocate for policies that support people with mental illness and their families. For more information, please visit NAMI.

About Ellipsis Health
Ellipsis Health was founded with the belief that a person's mental health should have the same priority as one's physical health. The company saw an opportunity to connect the dots between the two - giving voice to a new standard of mental health care. By harnessing the unique power of the human voice as a biomarker for mental wellbeing, along with machine learning and AI, Ellipsis Health has established the only clinically validated vital sign for mental health. Its technology identifies, measures, and monitors the severity of stress, anxiety, and depression at scale by analyzing a short sample of natural speech to create an objective and scalable clinical decision support tool. Through partnerships with providers, payers, employers and digital health companies, Ellipsis Health is working to positively impact the quality of care, shorten the time to diagnosis, drive workflow efficiencies, reduce costs and improve patient outcomes. For more information, visit https://www.ellipsishealth.com.

SOURCE Ellipsis Health